Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection

Clicks: 290
ID: 119952
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
RCDI patients have increased numbers of antibiotic-resistant organisms. FMT is effective in the eradication of pathogenic antibiotic-resistant organisms and elimination of ABR genes.
Reference Key
b2016clinicalfecal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Millan B;Park H;Hotte N;Mathieu O;Burguiere P;Tompkins TA;Kao D;Madsen KL;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2016
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27025836
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male aged middle aged 80 and over Clinical Trial drug resistance fecal microbiota transplantation* feces / microbiology anti-bacterial agents / pharmacology enterocolitis pseudomembranous / therapy* bacterial / genetics* pmid:27025836 pmc4885654 doi:10.1093/cid/ciw185 braden millan heekuk park karen l madsen clostridium difficile / drug effects* clostridium difficile / genetics pseudomembranous / microbiology gastrointestinal microbiome / genetics*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.